Could a quick ultrasound replace X-Rays for osteoporosis diagnosis?
NCT ID NCT06371755
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares a new ultrasound technology called REMS with the standard DXA scan for measuring bone density. Researchers will enroll 296 women aged 30-80 to see if REMS is as accurate and reliable as DXA, but without using radiation. If it works, it could offer a faster, safer way to diagnose osteoporosis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ultrasound examination with REMS technology (device)
- What this could lead to
- If successful, this could provide a safer, radiation-free way to diagnose osteoporosis, making bone density testing easier and more accessible.
- What could go wrong
- This is an early-stage comparison study, not a treatment trial. The new method may not be as accurate as DXA, and results may not apply to men or people with severe obesity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 296 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2019
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients scheduled for lumbar and/or femoral DXA examination, * female sex, * age range 30-80 years (for repeatability study), age range 50-70 years (for accuracy study), * absence of severe obesity (BMI \< 40 kg/m2), * absence of severe walking difficulties, * cognitive underwriting of informed consent. Exclusion Criteria: * Male sex, * severe walking difficulties, * age below 30 years or over 80 years, * severe obesity (BMI \> 40 kg/m2), * declared pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoporosis diagnosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
RECRUITINGMilan, MI, 20157, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.